Vincent A. Forlenza, also known as Vince, has been the Chairman of Becton, Dickinson and Company since July 1, 2012 and has been its President since January 1, 2009 also Chief Executive Officer since October 1, 2011. Mr. Forlenza oversees Becton, Dickinson and Company's three business segments (BD Medical, BD Diagnostics and BD Biosciences), International and the Quality function. He served as the Chief Operating Officer of Becton, Dickinson and Company from July
Becton, Dickinson and Company (BD) is an American medical technology company that manufactures and sells medical devices, instrument systems and reagents. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs nearly 30,000 people in more than 50 countries throughout the world. In fiscal year ending September 30, 2009, 60% of BD sales were generated from non-U.S. markets.
The company's customers include healthcare institutions, science researchers, clinical laboratories, the pharmaceutical industry and the general public. BD was one of the first companies to sell U.S.-made glass syringes. It was also a pioneer in the production of hypodermic needles. Today, BD is divided into three segments: BD Medical, BD Diagnostics and BD Biosciences. BD is ranked #336 in the 2014 Fortune 500 list.